Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9612 posts found.

DIA’s Global Clinical Trials Transparency Conference & Clinical Trials Regulations Conference

August 31, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Disclosure and transparency of clinical trial information is taking on new dimensions in the EU and US. Moreover, while the …
News
Press release
astrazeneca-sign

AZ’s lupus drug fails to curb lupus activity at Phase 3

August 31, 2018 Medical Communications, Research and Development AstraZeneca, Lupus, anifrolumab, pharma

AstraZeneca and its biologics R&D arm MedImmune have released a statement admitting that their fully human monoclonal antibody anifrolumab failed …
News

Bristol-Myers Squibb appoints Christopher Boerner as new Executive Vice President and Chief Commercial Officer

August 30, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMS, Bristol-Myers Squibb, bristol myers squibb, cco, chief commercial officer, christopher boerner, executive vice president, murdo gordon

Bristol Myers Squibb has announced that Dr Christopher Boerner will take over from Murdo Gordon as executive Vice President and …
Appointment
psm_v46_d168_mesial_view_of_the_human_brain

Drug slows brain shrinkage associated with progressive multiple sclerosis, study shows

August 30, 2018 Research and Development MS, brain, ibudilast, neuroscience, research

The multiple sclerosis drug ibudilast, slowed brain shrinkages in patients with progressive MS, a study published in the New England …
News
medicinal_cannabis_uk_review

CBD dampens activity in brain regions associated with psychosis, study shows

August 30, 2018 Research and Development CBD, King's College London, Kings College London, Marijuana, psychosis, study

Cannabidiol (CBD), one of the major constituents of cannabis, may be beneficial for patients with psychotic disorders due to its …
News
astrazeneca_building_white

AstraZeneca’s once-weekly auto-injector Bydureon BCise wins EU approval in type 2 diabetes

August 30, 2018 Research and Development, Sales and Marketing AstraZeneca, Bydureon, EU, Europe, diabetes, pharma, type 2 diabetes

AstraZeneca has announced that its auto-injector Bydureon BCise (exenatide 2mg prolonged-release suspension) has been approved by the European Commission for …
News
jazz_pharma

Jazz Pharma’s acute myeloid leukaemia drug scores EU approval

August 29, 2018 Research and Development, Sales and Marketing Vyxeos, acute myeloid leukaemia, jazz pharmaceuticals, leukaemia, pharma

Jazz Pharmaceuticals has revealed that its advanced liposomal formulation Vyxeos has received approval from the European Commission for the treatment …
News
shutterstock_168864905

Emergent snaps up Adapt and its opioid overdose therapy for $735m

August 29, 2018 Research and Development, Sales and Marketing Emergent, Narcan, naloxone, opioid crisis, opioids, pharma

Emergent BioSolutions has announced it has signed an agreement to acquire Adapt Pharma at a valuation of $735 million, a …
News

NHS guidance suggests mental health therapists should be brought into GP surgeries

August 29, 2018 Research and Development England, GP, NHS, guidance, psychology, psychotherapy

New NHS guidelines will encourage doctors to incorporate mental health therapists into practice surgeries in an effort to bring more …
News
16792957331_d9572dbdf4_z

FDA warns against King Bio products after company expands recall

August 29, 2018 Research and Development Contamination, FDA, homeopathy, king bio, recall

The US Food and Drug Administration is warning consumers and pet owners not to use products that have been manufactured …
News
novartis_mit_us

Novartis to create 450 new jobs at Aargau site after Kymriah thumbs up

August 29, 2018 Research and Development CAR T, CAR-T, Jobs, Kymriah, Novartis

Swiss multinational Novartis is set to create up to 450 new jobs following the investment of 90 million Swiss Francs …
News
eisa0008_web

Eisai’s weight loss drug lorcaserin found safe in major study

August 28, 2018 Manufacturing and Production, Research and Development, Sales and Marketing Eisai, lorcaserin, safety, study, weight loss

Eisai’s weight loss drug lorcaserin does not increase people’s risk of major cardiovascular events according to a study of 12,000 …
News
26022266362_1bf5a2747e_z

Researchers develop anti-nicotine addiction drugs

August 28, 2018 Manufacturing and Production, Research and Development, Sales and Marketing addiction, candidates, drug, nicotine, research, washington state university

Washington State University researchers have developed an array of drug candidates which they believe may help tackle addiction to nicotine. …
News
top_10_image

Top Ten most popular articles on Pharmafile.com this week

August 24, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing India, Ireland, manufacturin, san francisco, top 10

As summer comes to an end manufacturing dominated the news, with jobs lost in both Ireland and San Francisco. Meanwhile …
News

GE Healthcare set to open biotech hub in Uppsala, Sweden

August 23, 2018 Manufacturing and Production, Research and Development GE Healthcare, Sweden, Testa Centre, Uppsala, biotech

The American multinational GE Healthcare is opening a 27,000-sq-ft innovation centre in Uppsala, Sweden in an effort to boost the …
News
The Gateway to Local Adoption Series

Latest content

Kayentis and RWS partner to improve clinical trial data confidence

April 17, 2026

MHRA expands its pioneering AI Airlock programme with £3.6m funding boost

April 16, 2026

Ardena opens new US bioanalytical laboratory

April 15, 2026

Gesynta Pharma doses first patient in endometriosis phase 2 trial

April 14, 2026

Astellas Pharma’s new non-hormonal menopausal hot flush treatment Veoza can be used in the NHS, NICE says

April 13, 2026